Biotechnology | FDA | Influenza | Vaccine
FDA approved quadrivalent formulation of Fluarix
On Dec. 14, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved GlaxoSmithKline’s quadrivalent formulation…
-
-
A milestone in protection from influenza was reached with FDA approval for Novartis to manufacture seasonal influenza vaccine using cell-based technology in a US facility
On Nov. 20, 2012, the FDA approved a seasonal flu vaccine produced by Novartis using animal cell culture…
-
Biotechnology | FDA | Influenza | Vaccine
FDA approved first seasonal influenza vaccine manufactured using cell culture technology
On Nov. 20, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved first seasonal influenza…
-
ACIP recommended universal Influenza vaccination for those 6 months of age and older
On Feb. 24, 2010, the Immunization Practices Advisory Committee (ACIP) recommended universal Influenza vaccination for those 6 months…
-
FDA approved high-dose inactivated influenza vaccine for people ages 65 years and older
On Dec. 23, 2009, the FDA approved high-dose inactivated influenza vaccine (Fluzone High-Dose) for people ages 65 years…
-
swine flu outbreak declared a national emergency
On Oct. 24, 2009, President Barack Obama declared the swine flu (N1n1) outbreak a national emergency. The declaration…
-
WHO declared world at the start of 2009 influenza pandemic
On Jun. 11, 2009, the Dr. Margaret Chan, Director-General World Health Organization (WHO), declared the world was at…
-
The CDC identified the novel H1N1 influenza virus
On Apr. 15, 2009, the U.S. Centers for Disease Control and Prevention (CDC) identified the novel H1N1 influenza…
-
Physicians used point of care rapid immunoassay tests to provide influenza results during H1N1 pandemic
In Apr. 2009, physicians used point of care rapid immunoassay tests to provide influenza results within 15 minutes…
-
An increased risk of narcolepsy was found following vaccination with Pandemrix
In 2009, an increased risk of narcolepsy (a chronic sleep disorder) was found following vaccination with Pandemrix, a…
-
ACIP voted to expand influenza recommendation to include vaccination for children ages 6 months-18 years
On Feb. 27, 2008, the Immunization Practices Advisory Committee (Immunization Practices Advisory Committee (ACIP) voted to expand influenza…
-
The CDC received FDA approval for a highly sensitive influenza PCR assay
In 2008, the U.S. Centers for Disease Control and Prevention (CDC) received U.S. Food and Drug Administration (FDA)…
-
CDC | Diagnostics | Influenza | Therapeutics
The Influenza Reagent Resource was established by the CDC
In 2008, the Influenza Reagent Resource (IRR) was established by the Centers for Disease Control and Prevention (CDC)…
-
CDC published Interim Pre-pandemic Planning Guidance Strategy for Pandemic Influenza Mitigation in the U.S.
On Feb. 1, 2007, the Centers for Disease Control and Prevention (CDC) released its long-awaited disease containment strategy…
-
FDA licensed the refrigerator formulation of FluMist
On Jan. 9, 2007, the U.S. Food and Drug Administration (FDA) announced it had approved a refrigerated form…
-
Biotechnology | CDC | Influenza | Therapeutics | Vaccine
Human infection with a novel influenza virus was added to the nationally notifiable disease list
On Jan. 9, 2007, the Executive Committee of the Council of State and Territorial Epidemiologists approved an interim…
-
Biotechnology | CDC | Diagnostics | Influenza | Vaccine
CDC stopped recommending adamantanes during 2005 season after high levels of influenza A (H3N2) virus resistance
On Jan. 17, 2006, the Centers for Disease Control and Prevention (CDC) announced that it had stopped recommending…
-
The genome of the 1918 H1N1 pandemic influenza virus was sequenced
On Oct. 7, 2005, Jeffery Taubenberger, AH Reid, AE Krafft, Karen Bijwaard and Thomas Fanning published a report…
-
HHS Pandemic Influenza Plan was published
In 2005 and 2006, the White House Homeland Security Council outlined the National Strategy for Pandemic Influenza to…
-
Contracts awarded to Aventis Pasteur and Chiron to develop vaccine against H5N1 avian influenza virus
On May 27, 2004, the National Institute of Allergy and Infectious Diseases (NIAID) announced it had awarded contracts…
-
ACIP voted to recommend influenza vaccination for children aged 6 to 23 months
On Oct. 15, 2003, the Immunization Practices Advisory Committee (ACIP) voted to recommend that children 6 to 23…
-
The ACIP encouraged that children 6 to 23 months of age be vaccinated annually against influenza
On Jan. 1, 2003, the Advisory Committee on Immunization Practices (ACIP) encouraged that children 6 to 23 months…
-
Neuraminidase inhibitors Tamiflu and Relenza were licensed to treat influenza infection
On Oct. 27, 1999, Hoffmann-La Roche and Gilead Sciences announced that Roche’s TAMIFLU™ (oseltamivir phosphate) has been approved…
-
Roche received FDA approval of TAMIFLU, first pill to treat most common strains of influenza (A&B)
On Oct. 27, 1999, Hoffmann-La Roche and Gilead Sciences announced that Roche’s TAMIFLU (oseltamivir phosphate) had been approved…
-
A pandemic planning framework was published by the World Health Organization
In April 1999, a pandemic planning framework was published by the World Health Organization (WHO) that emphasized the…
-
Biotechnology | Diagnostics | Influenza | Vaccine | WHO
FluNet, a web-based flu surveillance tool, was launched by the WHO
In 1997, FluNet, a global web-based tool for influenza virological surveillance was launched. It is a critical tool…
-
Rimantadine was approved by the FDA to treat influenza A
In 1994, Rimantadine, derived from amantadine, was approved by the Food and Drug Administration (FDA) to treat influenza…
-
Biotechnology | FDA | Influenza | Vaccine
The FDA approved PRP-OMP for routine administration to infants beginning at 2 months of age
On Dec. 13, 1990, the U.S. Food and Drug Administration (FDA) approved Haemophilus b Conjugate Vaccine (Meningococcal Protein…
-
The FDA approved the use of HbOC for routine administration to infants beginning at 2 months of age
On Oct. 4, 1990, the FDA approved the use of Haemophilus b Conjugate Vaccine (Diphtheria CRM 197 Protein…
-
Biotechnology | CDC | Diagnostics | Infectious Disease | Therapeutics | Vaccine | WHO
The CDC established a World Health Organization (WHO) collaborating center for disaster preparedness
In 1989, the U.S. Centers for Disease Control and Prevention (CDC) established a World Health Organization (WHO) collaborating…
